CliffBio

Bristol Myers Squibb

Patent cliffs & loss of exclusivity

Bristol Myers Squibb is a Princeton, New Jersey biopharmaceutical company formed in 1989 through the merger of Bristol-Myers and Squibb. It develops medicines in oncology, hematology, immunology, cardiovascular disease, neuroscience and cell therapy.

Company

Also Known AsBMY
AngelList URLhttps://angel.co/bristol-myers-squibb-6
Apple App Store URLhttps://apps.apple.com/us/developer/bristol-myers-squibb/id499869937
CAGE Code1M8G6
Legal NameBristol-Myers Squibb Co.
Company Operating StatusActive
Contact Page URLhttps://www.bms.com/about-us/contact-us.html
Crunchbase URLhttps://www.crunchbase.com/organization/bristol-myers-squibb#section-overview

9 upcoming patent cliffs

DrugIngredientTypeCliff
  1. DAKLINZADACLATASVIR DIHYDROCHLORIDESmall mol.Aug 2027
  2. VIDAZAAZACITIDINESmall mol.May 2029
  3. DAKLINZADACLATASVIR DIHYDROCHLORIDESmall mol.Jun 2031
  4. DAKLINZADACLATASVIR DIHYDROCHLORIDESmall mol.Jun 2031
  5. ABRAXANEPACLITAXELSmall mol.Jul 2034
  6. INREBICFEDRATINIB HYDROCHLORIDESmall mol.Sep 2039
  7. COBENFYTROSPIUM CHLORIDE; XANOMELINE TARTRATESmall mol.Oct 2039
  8. COBENFYTROSPIUM CHLORIDE; XANOMELINE TARTRATESmall mol.Oct 2039
  9. COBENFYTROSPIUM CHLORIDE; XANOMELINE TARTRATESmall mol.Oct 2039
  10. THALOMIDTHALIDOMIDESmall mol.—
  11. THALOMIDTHALIDOMIDESmall mol.—
  12. THALOMIDTHALIDOMIDESmall mol.—
  13. THALOMIDTHALIDOMIDESmall mol.—
  14. ISTODAXROMIDEPSINSmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Bristol Myers Squibb — patent cliffs & loss of exclusivity | CliffBio